TherapeuticsMD | TXMD - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 33.67B 140M 2026-06
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Cipla INR 241.47B 7.71B 2026-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 137.28M 10.74M 2026-03
CSL USD 11.85B 1000K 2025-12
Grifols EUR 5.96B 316.31M 2025-12
Novo Nordisk DKK 31.89B 145.42B 2026-06
Pfizer USD 41.36B 1.46B 2026-06
TherapeuticsMD USD 11.82M 303K 2024-06